Source: ET Bureau
The company joins a list of others among India Inc who are working on developing solutions to arrest the spread of the Coronavirus.
Technology services provider Tata Consultancy Services’ research and innovation division is developing platforms to track COVID patient numbers, for clinical trials and is also working on drug discovery.
The company joins a list of others among India Inc who are working on developing solutions to arrest the spread of the Coronavirus.
Addressing the developments that the company has made, TCS chief executive Rajesh Gopinathan said in a LinkedIn post, “We are leveraging the TCS R&D infrastructure to run multiple threads looking for opportunities to support the governments, both India and abroad. Some examples are COVID-19 patient tracker, creating a quick and light platform for clinical trials systems to rapidly collate effectiveness data in collaboration with pharma and medical institutions, drug molecule discovery using our patented technology and frameworks, exploring promising ideas for affordable and effective ventilators, kits, etc.”
On the company’s activities in supporting critical infrastructure during this time, he added, “We are helping rapid rollout of Covid-19 tracking systems, supporting fragile supply chain systems across industries, ensuring critical payroll processes so that workers get paid in time, helping build and power platforms and processes feverishly for discovery of vaccines, helping universities continue their classes online, and ensuring homes have the network connectivity without which remote working wouldn’t be possible in time of today’s crisis.”
Gopinathan said that the company is supporting the Indian government in executing the social distancing program laid out by it.
